CareDx reports Q2 2026 revenue of $132M, raises full-year 2026 guidance to $490-500M
Second quarter 2026 revenue increased 52% year-over-year to $132 million. The company raised its 2026 revenue guidance to $490M-$500M and AEBITDA guidance to $66M-$78M. The growth was driven by strong testing services volume and revenue expansion.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day